Shares of DermTech (DMTK) Risen 186% Over A Month

After announcing that its test had earned insurance coverage, the shares of biotech firm DermTech, Inc. (DMTK) started rising last month. The rally is still going on as the stock has added more than 186% over one month. . Now the business can depend on market growth, as with the DermTech Pigmented Lesion Assay (PLA) genomic test, more patients will be able to afford to test.

For PLA studies, the American insurance provider Geisinger Health System has approved medical insurance payments. Such studies are the newest early warning technology for melanoma (skin cancer). Its particularity is high precision: at an early stage, the risk of losing cancer is less than 1 percent. This is particularly important for this condition, as timely diagnosis decreases the risk of a dangerous course of the disease. Early disease identification systems are being implemented in certain countries’ health services as the most reliable means of sustaining health and reducing costs.

Naturally, the announcement of the introduction of DermTech technology became the engine of price rise of the stock as it has risen 27% on December 30 session. In the US health insurance market, Geisinger is one of the participants. Geisinger’s case, however, can contribute to a sequence of similar choices by other insurers. The fact that the PLA test was historically approved for reimbursement by Illinois insurance providers Blue Cross Blue Shield and California Blue Shield is in favor of this.

What effect Geisinger’s acceptance would have on the financial results of DermTech is not yet apparent. In February 2021, the organization expects to issue the next update (for the fourth quarter).


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


At the January 15 trading, DermTech, Inc. (DMTK) was down -1.69% to $39. The capitalization of the market now stands at $945 million

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Recent Articles

Intel (INTC) Intends to appeal against Court order for Violation of VLSI Tech

In the last quarter, Intel's (INTC) share price rose 29%. On Tuesday, Intel fell 2.6% after Federal Judge Jim Davis ruled the company must...

The Facts You Need to Know about Itron Inc. (ITRI) Moving Forward

Itron, Inc. (NASDAQ: ITRI) released a positive update for the fourth quarter and full-year 2020. This quarter was highlighted by a record portfolio of...

One stock you can’t skip: Bionano Genomics Inc. [BNGO]

Bionano Genomics Inc. (BNGO) stock prices have grown nearly 1,000% in the past 12 months. Despite this, some analysts feel that the shares have...

What the sentiment indicator is Signaling: CEVA Inc (CEVA)

CEVA, Inc. (NASDAQ: CEVA) reported its fourth-quarter report on Tuesday, February 16; the company signed 21 new agreements generating record revenues. CEVA provides OEMs with...

A Stock Check: Which direction Pinterest Inc (PINS) will move from here?

The social networking company Pinterest Inc (PINS) rose 226% in the past year. If the price has increased significantly, is it worthwhile to acquire...

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.